is semaglutide still on the shortage list As of February 21, 2025, FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Hims & Hers can't sell
Description
GLP-1 receptor (GLP-1R) agonists, like liraglutide, have shown analgesic effects by modulating pain hypersensitivity in animal models of inflammatory and neuropathic pain
Consumers would be spending in other categories, though, so the household microeconomics of the GLP-1s could increase demand for new clothing, gym memberships, and perhaps even tourism if the individual feels more mobile to travel
News from food industry suppliers
Head-to-head SURMOUNT-5 data: Zepbound delivered 20.2% vs Wegovy's 13.7% weight loss
On just the Hims Hers platform alone, nearly 80,000 individuals have shared they cannot access branded GLP-1 medications
RGB Plate Segments: 12 (2 x 6)
